Evercore ISI lowered the firm’s price target on Healthpeak Properties (DOC) to $22 from $23 and keeps an Outperform rating on the shares. In a broad REIT note, the analyst rolled forward models to incorporate the firm’s 2027 AFFO estimates into its price target framework.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak upgraded to Outperform from Market Perform at Raymond James
- Healthpeak Properties price target lowered to $21 from $22 at Morgan Stanley
- Deutsche downgrades Healthpeak to Hold on biotech challenges
- Healthpeak Properties downgraded to Hold from Buy at Deutsche Bank
- Ex-Dividend Date Nearing for These 10 Stocks – Week of August 18, 2025